Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study

Abstract

Background Few large projects have evaluated the factors that influence the HIV RNA concentrations (viral load) in cerebrospinal fluid (CSF) during antiretroviral therapy (ART) over time. We aimed to determine the correlates of HIV RNA in CSF in a large cohort. Methods We analysed longitudinal data from adults living with HIV in the US CHARTER cohort. Participants in the CHARTER study were recruited from six US academic medical centres-in Baltimore (MD), Galveston (TX), New York (NY), St Louis (MO), San Diego (C92A), and Seattle (WA). Participants in this study had been assessed at least three times between Sept 4, 2003, and Sept 14, 2010, and were taking ART and underwent venous and lumbar puncture with measurement of HIV RNA concentration at all assessments. The lower limit of quantification of the HIV RNA assays was 50 copies per mL. Data were analysed with longitudinal mixed effects logistic regression to identify correlates of HIV RNA concentration (as a binary [detectable or not] and as a continuous variable) in CSF over time. We tested demographic characteristics, plasma HIV RNA, nadir and current CD4 cell count in blood, current CD8 cell count in blood, estimated duration of HIV infection, AIDS diagnosis, duration of ART, adherence to ART, ART characteristics, and CSF characteristics as potential correlates. Findings At the time of analysis, 2207 assessments from 401 participants met the criteria for inclusion in this study. Mean duration of observation was 33•7 months (range 12-84). HIV RNA concentrations in 710 (32•2%) plasma specimens and in 255 (11•6%) CSF specimens were greater than the lower limit of quantification. The best multivariate model of HIV RNA concentration in CSF greater than the lower limit of quantification over time included increased plasma HIV RNA concentration (odds ratio 18•0 per 1 log 10 copy per mL, 95% CI 11•3 to 28•8; p<0•0001), increased CSF leucocyte count (2•01 per 5 cells per μL, 1•61 to 2•39; p<0•0001), decreased CD4 cell count (0•53 per 5 squareroot cells per μL, 0•35 to 0•79; p=0•0025), decreased CNS penetration-effectiveness value (0•71 per unit, 0•56 to 0•92; p=0•0078), increased CD8 cell count (1•51 per 5 square-root cells, 1•11 to 2•06; p=0•0089), and protease inhibitor use (3•26, 1•04 to 10•23; p=0•039; model R²=0•22, p<0•0001). Analyses of continuous HIV RNA concentration in CSF that accounted for censoring below the lower limit of quantification had similar findings, although increased HIV RNA concentrations in CSF were also associated with black ethnicity (change in log 10 HIV RNA concentration in CSF 0•205, 0•0367 to 0•3733; p=0•017), increased total protein in CSF (0•0025,-0•0002 to 0•0052; p=0•069), and the presence of addictive-drug metabolites in urine (0•103,-0•013 to 0•219; p=0•081). Interpretation The identified correlates of HIV RNA concentration in CSF during ART could strengthen clinical prediction of risk for failure to achieve or maintain HIV RNA suppression in CSF. Because most participants in this analysis were ART-experienced and were taking a th...

Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance

“…HIV-1 RNA is detected in the cerebrospinal fluid (CSF) throughout the course of untreated systemic infection, beginning early after initial exposure [ 1 – 3 ] and continuing until suppressed by antiretroviral therapy (ART) [ 4 – 7 ]. Among untreated people living with HIV infection (PLWH), only elite controllers consistently exhibit CSF HIV-1 RNA below the clinical laboratory lower limits of quantitation (LLoQ) [ 8 , 9 ].…”

New Insights on the Mobility of Viral and Host Non-Coding RNAs Reveal Extracellular Vesicles as Intriguing Candidate Antiviral Targets

“…Interestingly, exosomes can cross the blood-brain barrier [119]. This raises the possibility that HIV-associated neurocognitive disorders (HAND) which enigmatically are not prevented by antiretroviral therapy may in fact result from an ability of HIV to infect cells in the absence of the CD4 receptor and the chemokine CCR5 and CXCR4 co-receptors by exploiting exosomes to traffic viral agents [120][121][122]. Yet another example of RNA transport facilitated by exosomes involves a tick-borne Langat virus (LGTV), a flavivirus like tick-borne encephalitis virus (TBEV) [62].…”

Linking Neuroinflammation and Extracellular Free Water in HIV Infection: A Longitudinal Study

“…Evaluation of brain HIV infection in HIV-infected individuals is currently limited to indirect measurements such as those performed using cerebrospinal uid (CSF). However, CSF viral load is undetectable in >90% of well-treated individuals with undetectable plasma viral load, thus, CSF viral load may not adequately represent the extent of intra-parenchymal infection 6 .…”